The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
An Enterococcus faecalis ABC Homologue (Lsa) Is Required for the Resistance of This Species to Clindamycin and Quinupristin-Dalfopristin
Open accessAbstract
Enterococcus faecalis isolates are resistant to clindamycin (CLI) and quinupristin-dalfopristin (Q-D), and this is thought to be a species characteristic. Disruption of a gene ( abc-23 , now designated lsa , for “lincosamide and streptogramin A resistance”) of E. faecalis was associated with a ≥40-fold decrease in MICs of Q-D (to 0.75 μg/ml), CLI (to 0.12 to 0.5 μg/ml), and dalfopristin (DAL) (to 4 to 8 μg/ml) for the wild-type E. faecalis parental strain (Q-D MIC, 32 μg/ml; CLI MIC, 32 to 48 μg/ml; DAL MIC, 512 μg/ml). Complementation of the disruption mutant with lsa on a shuttle plasmid resulted in restoration of the MICs of CLI, Q-D, and DAL to wild-type levels. Under high-stringency conditions, lsa was found in 180 of 180 isolates of E. faecalis but in none of 189 other enterococci. Among 19 erm (B)-lacking Enterococcus faecium strains, 9 (47%) were highly susceptible to CLI (MIC, 0.06 to 0.25 μg/ml) and had DAL MICs of 4 to 16 μg/ml; for the remaining erm (B)-lacking E. faecium strains, the CLI and DAL MICs were 4 to >256 and 2 to >128 μg/ml, respectively. In contrast, none of 32 erm (B)-lacking E. faecalis strains were susceptible (CLI MIC range, 16 to 32 μg/ml; DAL MIC range, ≥32 μg/ml). When lsa was introduced into an E. faecium strain initially susceptible to CLI, the MICs of CLI and DAL increased ≥60-fold and that of Q-D increased 6-fold (to 3 to 6 μg/ml). Introduction of lsa into two DAL-resistant (MICs, >128 μg/ml), Q-D-susceptible (MICs, 0.5 and 1.5 μg/ml) E. faecium strains (CLI MICs, 12 and >256 μg/ml) resulted in an increase in the Q-D MICs from 3- to 10-fold (to 8 and >32 μg/ml), respectively. Although efflux was not studied, the similarity (41 to 64%) of the predicted Lsa protein to ABC proteins such as Vga(A), Vga(B), and Msr(A) of Staphylococcus aureus and YjcA of Lactococcus lactis and the presence of Walker A and B ATP-binding motifs suggest that this resistance may be related to efflux of these antibiotics. In conclusion, lsa appears to be an intrinsic gene of E. faecalis that explains the characteristic resistance of this species to CLI and Q-D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, chromosomally encoded pumps can explain the inherent resistance of some bacterial species to a particular antibiotic (e.g. E. faecalis intrinsic resistance to streptogramin A, see below) (45).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [45]
In the citing paper
“Finally, another predicted efflux pump is Lsa (encoded by the chromosomal gene lsa), which is responsible for the intrinsic resistance of E. faecalis to lincosamides and streptogramin A (LSA phenotype) (44, 45).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
Preparation of Genomic DNA from Bacteria
Wilson, K. J. (2001) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb0204s56 · Cited by 2,082
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,887
Self-citationThe Complete Genome Sequence of the Lactic Acid Bacterium Lactococcus lactis ssp. lactis IL1403Preprint
Bolotin, A., Wincker, P., Mauger, S., Jaillon, O., Malarme, K., Weissenbach, J., Ehrlich, S. D., & Sorokin, A. (2001) · Genome Research · doi:10.1101/gr.169701 · Cited by 1,161
Hyde, S. C., Emsley, P., Hartshorn, M. J., Mimmack, M. M., Gileadi, U., Pearce, S. R., Gallagher, M. P., Gill, D. R., Hubbard, R. E., & Higgins, C. F. (1990) · Nature · doi:10.1038/346362a0 · Cited by 1,145
The Complete Genome Sequence of the Lactic Acid Bacterium Lactococcus lactis ssp. lactis IL1403
Bolotin, A., Wincker, P., Mauger, S., Jaillon, O., Malarme, K., Weissenbach, J., Ehrlich, S. D., & Sorokin, A. (2001) · Genome Research · doi:10.1101/gr.gr-1697r · Cited by 1,139
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 894
Self-citationBacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 629
In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis
Sahm, D. F., Kissinger, J. C., Gilmore, M. S., Murray, P. R., Mulder, R., Solliday, J., & Clarke, B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1588 · Cited by 497
Murray, B. E., Singh, K. V., Heath, J. D., Sharma, B. R., & Weinstock, G. M. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.9.2059-2063.1990 · Cited by 487
Self-citationRoss, J. I., Eady, E. A., Cove, J. H., Cunliffe, W. J., Baumberg, S., & Wootton, J. C. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb00696.x · Cited by 358
Montecalvo, M. A., Horowitz, H. W., Gedris, C. A., Carbonaro, C. A., Tenover, F. C., Issah, A. R., Cook, P., & Wormser, G. P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1363 · Cited by 316
Diversity among Multidrug-Resistant Enterococci
Murray, B. E. (1998) · Emerging infectious diseases · doi:10.3201/eid0401.980106 · Cited by 286
Self-citationMultidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1.
van Veen, H. W., Venema, K., Bolhuis, H., Oussenko, I. A., Kok, J. W., Poolman, B., Driessen, A. J. M., & Konings, W. N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10668 · Cited by 282
Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States
Coque, T. M., Tomayko, J. F., Ricke, S. C., Okhyusen, P. C., & Murray, B. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2605 · Cited by 274
Self-citationEvolutionary origins of multidrug and drug-specific efflux pumps in bacteria
Saier, M. H., Paulsen, I. T., Sliwinski, M. K., Pao, S. S., Skurray, R. A., & Nikaido, H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.3.265 · Cited by 262
Evolution of ATP-binding cassette transporter genes
Dean, M. C. (1995) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(95)80011-s · Cited by 239
Leclercq, R., & Courvalin, P. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1273 · Cited by 230
Peschke, U., Schmidt, H., Zhang, H., & Piepersberg, W. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02338.x · Cited by 216
Murray, B. E., Singh, K. V., Ross, R. P., Heath, J. D., Dunny, G. M., & Weinstock, G. M. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.16.5216-5223.1993 · Cited by 203
Self-citationWeisblum, B. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.suppl_a.63 · Cited by 198
Dubnau, D. A., & Nomura, M. (1984) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238409102300 · Cited by 180
Singh, K. V., Coque, T. M., Weinstock, G. M., & Murray, B. E. (1998) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1998.tb01180.x · Cited by 179
Self-citationAllignet, J., Loncle, V., & Solh, N. E. (1992) · Gene · doi:10.1016/0378-1119(92)90488-b · Cited by 147
Evidence for natural gene transfer from gram-positive cocci to Escherichia coli
Brisson-Noël, A., Arthur, M., & Courvalin, P. M. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.4.1739-1745.1988 · Cited by 134
Murphy, E. (1985) · Journal of Bacteriology · doi:10.1128/jb.162.2.633-640.1985 · Cited by 129
Rende-Fournier, R., Leclercq, R., Galimand, M., Duval, J., & Courvalin, P. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2119 · Cited by 127
Quinupristin/dalfopristin: A therapeutic review
Allington, D. R. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80028-x · Cited by 126
Fogg, G. C., Gibson, C. M., & Caparon, M. G. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00345.x · Cited by 111
Singh, K. V., Malathum, K., & Murray, B. E. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.263-266.2001 · Cited by 99
Self-citationAllignet, J., & Solh, N. E. (1997) · Gene · doi:10.1016/s0378-1119(97)00464-2 · Cited by 98
Rosteck, P. R., Reynolds, P. A., & Hershberger, C. L. (1991) · Gene · doi:10.1016/0378-1119(91)90533-h · Cited by 97
Projan, S. J., Monod, M., Narayanan, C. S., & Dubnau, D. A. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.11.5131-5139.1987 · Cited by 95
Penicillin-Binding Protein 5 and Expression of Ampicillin Resistance in Enterococcus faecium
Rice, L. B., Carias, L. L., Hutton‐Thomas, R., Sifaoui, F., Gutmann, L., & Rudin, S. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1480-1486.2001 · Cited by 95
Geistlich, M., Losick, R. M., Turner, J. R., & Rao, R. N. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01374.x · Cited by 89
Ross, J. I., Eady, E. A., Cove, J. H., & Baumberg, S. (1995) · Gene · doi:10.1016/0378-1119(94)00833-e · Cited by 79
Quinupristin‐Dalfopristin: An Overview
Delgado, G., Neuhauser, M. M., Bearden, D. T., & Danziger, L. H. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.19.1469.34858 · Cited by 72
Olano, C., Rodriguez, A. M., Méndez, C., & Salas, J. A. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02305.x · Cited by 67
Bozdoğan, B., & Leclercq, R. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2720 · Cited by 65
Generation of auxotrophic mutants of Enterococcus faecalis
Li, X., Weinstock, G. M., & Murray, B. E. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.23.6866-6873.1995 · Cited by 62
Self-citationDuh, R.-W., Singh, K. V., Malathum, K., & Murray, B. E. (2001) · Microbial Drug Resistance · doi:10.1089/107662901750152765 · Cited by 58
Self-citationEnterococcus faecalis multi-drug resistance transporters: application for antibiotic discovery.
Davis, D. R., McAlpine, J. B., Pazoles, C. J., Talbot, M. K., Alder, E. A., White, C., Jonas, B. M., Murray, B. E., Weinstock, G. M., & Rogers, B. L. (2001) · PubMed · Cited by 54
Self-citationGenetic transformation of various species of Enterococcus by electroporation
Friesenegger, A., Fiedler, S., Devriese, L. A., & Wirth, R. (1991) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1991.tb04549.x · Cited by 48
Milton, I. D. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90377-z · Cited by 39
Matsuoka, M., Jánosi, L., Endou, K., & Nakajima, Y. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb08830.x · Cited by 36
Flagged first, then by citations
Research works printed but not linked: 2
- Sambrook J. E. F. Fritsch and T. Maniatis. 1989. Molecular cloning: a laboratory manual 2nd ed. Cold Spring Harbor Laboratory Press Cold Spring Harbor N.Y.
- Wirth, R., F. An, and D. B. Clewell. 1987. Highly efficient cloning system for Streptococcus faecalis: protoplast transformation, shuttle vectors, and applications, p. 25-27. In J. J. Ferretti and R. Curtiss III (ed.), Streptococcal genetics. American Society for Microbiology, Washington, D.C.
Cited by
Sorted by citations
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
The rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776
Self-citationStructure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems
Davidson, A. L., Dassa, E., Orelle, C., & Chen, J. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-07 · Cited by 1,477
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 803
Metadata
- Authors
- Singh, K. V., Weinstock, G. M., & Murray, B. E.
- Affiliations
- Center for the Study of Emerging and Reemerging Pathogens
- Baylor College of Medicine (US)
- The University of Texas Health Science Center at Houston (US)
- Corresponding author
- Murray, Barbara E.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2002-06
- Volume
- 46
- Issue
- 6
- Pages
- 1845-1850
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC127256
- OpenAlex
- W1980535030
- Cited by
- 263
- References
- 45
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 16 · 2023: 17 · 2022: 19 · 2021: 15 · 2020: 15 · 2019: 7 · 2018: 10 · 2017: 6 · 2016: 16 · 2015: 9 · 2014: 10 · 2013: 10 · 2012: 4
- FWCI
- 7.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service
- National Institute of Allergy and Infectious Diseases (R37AI047923, AI 47923, R01AI047923)
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Enterococcus faecalis, ABC transporters, clindamycin resistance, quinupristin-dalfopristin resistance, Enterococcus faecium, ermB gene, antibiotic resistance genes
- MeSH terms
- Amino Acid Sequence, Anti-Bacterial Agents, Clindamycin, DNA, Bacterial, Drug Resistance, Drug Therapy, Combination, Genes, Bacterial, Genetic Complementation Test, Microbial Sensitivity Tests, Molecular Sequence Data, Enterococcus faecalis, Virginiamycin, Reverse Transcriptase Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review